Advertisement

Vascular liver diseases: A sex-oriented analysis of the literature

      Abstract

      Vascular liver diseases are an heterogenous group of diseases that collectively represent an important health issue in the field of liver diseases. This narrative review was elaborated by the Special Interest Group (SIG) “Gender in Hepatology” of the Italian Association for the Study of the Liver (AISF). We aimed to review the current knowledge regarding the potential role of biological sex in patients with vascular liver diseases such as splanchnic vein thrombosis, hepatic vein thrombosis, porto-sinusoidal vascular disorder, and hereditary hemorrhagic telangiectasia. As vascular liver diseases commonly affect young individuals, including women in childbearing age, we also included a specific section on the management of pregnancy in these challenging patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. European association for the study of the liver. Electronic address eee. EASL Clinical Practice Guidelines: vascular diseases of the liver.
        J Hepatol. 2016; 64: 179-202
        • Northup P.G.
        • Garcia-Pagan J.C.
        • Garcia-Tsao G.
        • Intagliata N.M.
        • Superina R.A.
        • Roberts L.N.
        • Lisman T.
        • et al.
        Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the american association for the study of liver diseases.
        Hepatology. 2021; 73: 366-413
        • Senzolo M.
        • Riggio O.
        • Primignani M.
        Italian Association for the Study of the Liver ad h. Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee.
        Dig Liver Dis. 2011; 43: 503-514
        • Germani G.
        • Zeni N.
        • Zanetto A.
        • Adam R.
        • Karam V.
        • Belli L.S.
        • O'Grady J.
        • et al.
        Influence of donor and recipient gender on liver transplantation outcomes in Europe.
        Liver Int. 2020; 40: 1961-1971
        • Guarino M.
        • Cossiga V.
        • Becchetti C.
        • Invernizzi F.
        • Lapenna L.
        • Lavezzo B.
        • Lenci I.
        • et al.
        Sarcopenia in chronic advanced liver diseases: a sex-oriented analysis of the literature.
        Dig Liver Dis. 2021;
        • Invernizzi F.
        • Cilla M.
        • Trapani S.
        • Guarino M.
        • Cossiga V.
        • Gambato M.
        • Morelli M.C.
        • et al.
        Gender and autoimmune liver diseases: relevant aspects in clinical practice.
        J Pers Med. 2022; 12
        • Burra P.
        • Zanetto A.
        • Germani G.
        Sex bias in clinical trials in gastroenterology and hepatology.
        Nat Rev Gastroenterol Hepatol. 2022;
        • Mauvais-Jarvis F.
        • Bairey Merz N.
        • Barnes P.J.
        • Brinton R.D.
        • Carrero J.J.
        • DeMeo D.L.
        • De Vries G.J.
        • et al.
        Sex and gender: modifiers of health, disease, and medicine.
        Lancet. 2020; 396: 565-582
        • Zanetto A.
        • Campello E.
        • Bulato C.
        • Gavasso S.
        • Saggiorato G.
        • Shalaby S.
        • Burra P.
        • et al.
        Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections.
        JHEP Rep. 2022; 4100493
        • Zanetto A.
        • Campello E.
        • Bulato C.
        • Gavasso S.
        • Farinati F.
        • Russo F.P.
        • Tormene D.
        • et al.
        Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death.
        J Hepatol. 2022;
        • Campello E.
        • Zanetto A.
        • Bulato C.
        • Maggiolo S.
        • Spiezia L.
        • Russo F.P.
        • Gavasso S.
        • et al.
        Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.
        Liver Int. 2021; 41: 2455-2466
        • Campello E.
        • Zanetto A.
        • Radu C.M.
        • Bulato C.
        • Truma A.
        • Spiezia L.
        • Senzolo M.
        • et al.
        Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis.
        Dig Liver Dis. 2021; 53: 879-888
        • Zanetto A.
        • Rodriguez-Kastro K.I.
        • Germani G.
        • Ferrarese A.
        • Cillo U.
        • Burra P.
        • Senzolo M.
        Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis.
        Transpl Int. 2018; 31: 1318-1329
        • Zanetto A.
        • Senzolo M.
        • Vitale A.
        • Cillo U.
        • Radu C.
        • Sartorello F.
        • Spiezia L.
        • et al.
        Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma.
        Dig Liver Dis. 2017; 49: 440-445
        • Senzolo M.
        • Garcia-Tsao G.
        • Garcia-Pagan J.C.
        Current knowledge and management of portal vein thrombosis in cirrhosis.
        J Hepatol. 2021; 75: 442-453
        • Zanetto A.
        • Campello E.
        • Pelizzaro F.
        • Farinati F.
        • Burra P.
        • Simioni P.
        • Senzolo M.
        Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications.
        Liver Int. 2022; 42: 1229-1240
        • Zanetto A.
        • Campello E.
        • Bulato C.
        • Gavasso S.
        • Saggiorato G.
        • Shalaby S.
        • Spiezia L.
        • et al.
        More pronounced hypercoagulable state and Hypofibrinolysis in patients with cirrhosis with versus without HCC.
        Hepatol Commun. 2021; 5: 1987-2000
        • Ageno W.
        • Riva N.
        • Schulman S.
        • Beyer-Westendorf J.
        • Bang S.M.
        • Senzolo M.
        • Grandone E.
        • et al.
        Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry.
        JAMA Intern Med. 2015; 175: 1474-1480
        • Ogren M.
        • Bergqvist D.
        • Bjorck M.
        • Acosta S.
        • Eriksson H.
        • Sternby N.H.
        Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies.
        World J Gastroenterol. 2006; 12: 2115-2119
        • Sogaard K.K.
        • Farkas D.K.
        • Pedersen L.
        • Sorensen H.T.
        Splanchnic venous thrombosis is a marker of cancer and a prognostic factor for cancer survival.
        Blood. 2015; 126: 957-963
        • Ageno W.
        • Dentali F.
        • Pomero F.
        • Fenoglio L.
        • Squizzato A.
        • Pagani G.
        • Re R.
        • et al.
        Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome.
        Thromb Haemost. 2017; 117: 794-800
        • Cernera G.
        • Di Minno A.
        • Amato F.
        • Elce A.
        • Liguori R.
        • Bruzzese D.
        • Di Lullo A.M.
        • et al.
        Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: a Potential Role for Sex and Thrombotic Localization.
        J Clin Med. 2020; 9
        • Colaizzo D.
        • Tiscia G.L.
        • Bafunno V.
        • Amitrano L.
        • Vergura P.
        • Lupone M.R.
        • Grandone E.
        • et al.
        Sex modulation of the occurrence of jak2 v617f mutation in patients with splanchnic venous thrombosis.
        Thromb Res. 2011; 128: 233-236
        • De Stefano V.
        • Vannucchi A.M.
        • Ruggeri M.
        • Cervantes F.
        • Alvarez-Larran A.
        • Iurlo A.
        • Randi M.L.
        • et al.
        Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.
        Blood Cancer J. 2016; 6: e493
        • Lijfering W.M.
        • Veeger N.J.
        • Middeldorp S.
        • Hamulyak K.
        • Prins M.H.
        • Buller H.R.
        • van der Meer J.
        A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families.
        Blood. 2009; 114: 2031-2036
        • Roach R.E.
        • Lijfering W.M.
        • Tait R.C.
        • Baglin T.
        • Kyrle P.A.
        • Cannegieter S.C.
        • Rosendaal F.R.
        Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts.
        J Thromb Haemost. 2015; 13: 1815-1822
        • Sant'Antonio E.
        • Guglielmelli P.
        • Pieri L.
        • Primignani M.
        • Randi M.L.
        • Santarossa C.
        • Rumi E.
        • et al.
        Splanchnic vein thromboses associated with myeloproliferative neoplasms: an international, retrospective study on 518 cases.
        Am J Hematol. 2020; 95: 156-166
        • Thatipelli M.R.
        • McBane R.D.
        • Hodge D.O.
        • Wysokinski W.E.
        Survival and recurrence in patients with splanchnic vein thromboses.
        Clin Gastroenterol Hepatol. 2010; 8: 200-205
        • Toque L.
        • Hamy A.
        • Hamel J.F.
        • Cesbron E.
        • Hulo P.
        • Robert S.
        • Aube C.
        • et al.
        Predictive factors of splanchnic vein thrombosis in acute pancreatitis: a 6-year single-center experience.
        J Dig Dis. 2015; 16: 734-740
        • Valeriani E.
        • Riva N.
        • Di Nisio M.
        • Ageno W.
        Splanchnic vein thrombosis: current perspectives.
        Vasc Health Risk Manag. 2019; 15: 449-461
        • Zanetto A.
        • Pellone M.
        • Senzolo M.
        Milestones in the discovery of Budd-Chiari syndrome.
        Liver Int. 2019; 39: 1180-1185
        • Alukal J.J.
        • Zhang T.
        • Thuluvath P.J.
        A nationwide analysis of budd-chiari syndrome in the United States.
        J Clin Exp Hepatol. 2021; 11: 181-187
        • Alukal J.J.
        • Zhang T.
        • Thuluvath P.J.
        Mortality and health care burden of Budd Chiari syndrome in the United States: a nationwide analysis (1998-2017).
        World J Hepatol. 2021; 13: 686-698
        • Harmanci O.
        • Kav T.
        • Peynircioglu B.
        • Buyukasik Y.
        • Sokmensuer C.
        • Bayraktar Y.
        Long-term follow-up study in Budd-Chiari syndrome: single-center experience in 22 years.
        J Clin Gastroenterol. 2013; 47: 706-712
        • Ibach M.
        • Eurich D.
        • Dobrindt E.
        • Lurje G.
        • Schoning W.
        • Ollinger R.
        • Pratschke J.
        • et al.
        Orthotopic liver transplantation for budd-chiari syndrome: observations from a 30-year liver transplant program.
        Medicina (Kaunas). 2021; 57
        • Ollivier-Hourmand I.
        • Allaire M.
        • Goutte N.
        • Morello R.
        • Chagneau-Derrode C.
        • Goria O.
        • Dumortier J.
        • et al.
        The epidemiology of Budd-Chiari syndrome in France.
        Dig Liver Dis. 2018; 50: 931-937
        • Parekh J.
        • Matei V.M.
        • Canas-Coto A.
        • Friedman D.
        • Lee W.M.
        Acute Liver Failure Study G. Budd-chiari syndrome causing acute liver failure: a multicenter case series.
        Liver Transpl. 2017; 23: 135-142
        • Rautou P.E.
        • Douarin L.
        • Denninger M.H.
        • Escolano S.
        • Lebrec D.
        • Moreau R.
        • Vidaud M.
        • et al.
        Bleeding in patients with Budd-Chiari syndrome.
        J Hepatol. 2011; 54: 56-63
        • Thuluvath P.J.
        • Alukal J.J.
        • Zhang T.
        A Scoring Model to Predict In-Hospital Mortality in Patients With Budd-Chiari Syndrome.
        Am J Gastroenterol. 2021; 116: 1905-1912
        • Thuluvath P.J.
        • Alukal J.J.
        • Zhang T.
        Acute liver failure in Budd-Chiari syndrome and a model to predict mortality.
        Hepatol Int. 2021; 15: 146-154
        • Fan J.
        • Wang Q.
        • Luo B.
        • Chen H.
        • Wang Z.
        • Niu J.
        • Yuan J.
        • et al.
        Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: a hospital-based observational study.
        J Gastroenterol Hepatol. 2020; 35: 1215-1222
        • Gao X.
        • Gui E.
        • Lu Z.
        • Ning X.
        • Zu M.
        • Zhang P.
        • Sun G
        Risk factors of recurrence among 471 Chinese patients with Budd-Chiari syndrome.
        Clin Res Hepatol Gastroenterol. 2015; 39: 620-626
        • Shalimar Sharma S
        • Gamanagatti S.R.
        • Chauhan A.
        • Vuyyuru S.K.
        • Elhence A.
        • Rout G.
        • et al.
        Acute-on-chronic liver failure in budd-chiari syndrome: profile and predictors of outcome.
        Dig Dis Sci. 2020; 65: 2719-2729
        • Zhang W.
        • Wang Q.Z.
        • Chen X.W.
        • Zhong H.S.
        • Zhang X.T.
        • Chen X.D.
        • Xu K.
        Budd-Chiari syndrome in China: a 30-year retrospective study on survival from a single center.
        World J Gastroenterol. 2018; 24: 1134-1143
        • Smalberg J.H.
        • Arends L.R.
        • Valla D.C.
        • Kiladjian J.J.
        • Janssen H.L.
        • Leebeek F.W.
        Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.
        Blood. 2012; 120: 4921-4928
        • Perarnau J.M.
        • Bacq Y.
        Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy.
        Semin Liver Dis. 2008; 28: 315-327
        • Van Wettere M.
        • Purcell Y.
        • Bruno O.
        • Payance A.
        • Plessier A.
        • Rautou P.E.
        • Cazals-Hatem D.
        • et al.
        Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome.
        J Hepatol. 2019; 70: 1123-1132
        • Van Wettere M.
        • Paulatto L.
        • Raynaud L.
        • Bruno O.
        • Payance A.
        • Plessier A.
        • Rautou P.E.
        • et al.
        Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.
        JHEP Rep. 2020; 2100097
        • Zhang R.
        • Qin S.
        • Zhou Y.
        • Song Y.
        • Sun L.
        Comparison of imaging characteristics between hepatic benign regenerative nodules and hepatocellular carcinomas associated with Budd-Chiari syndrome by contrast enhanced ultrasound.
        Eur J Radiol. 2012; 81: 2984-2989
        • Moucari R.
        • Rautou P.E.
        • Cazals-Hatem D.
        • Geara A.
        • Bureau C.
        • Consigny Y.
        • Francoz C.
        • et al.
        Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.
        Gut. 2008; 57: 828-835
        • Ding P.X.
        • Han X.W.
        • Liu C.
        • Zhang Y.
        • Cheng A.L.
        • Wu Y.
        • Liang X.X.
        • et al.
        Long-term outcomes of individualized treatment strategy in treatment of type I Budd-Chiari syndrome in 456 patients.
        Liver Int. 2019; 39: 1577-1586
        • Han G.
        • Qi X.
        • Zhang W.
        • He C.
        • Yin Z.
        • Wang J.
        • Xia J.
        • et al.
        Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center.
        Radiology. 2013; 266: 657-667
        • Hayek G.
        • Ronot M.
        • Plessier A.
        • Sibert A.
        • Abdel-Rehim M.
        • Zappa M.
        • Rautou P.E.
        • et al.
        Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome.
        Radiology. 2017; 283: 280-292
        • Seijo S.
        • Plessier A.
        • Hoekstra J.
        • Dell'era A.
        • Mandair D.
        • Rifai K.
        • Trebicka J.
        • et al.
        Good long-term outcome of Budd-Chiari syndrome with a step-wise management.
        Hepatology. 2013; 57: 1962-1968
        • Mentha G.
        • Giostra E.
        • Majno P.E.
        • Bechstein W.O.
        • Neuhaus P.
        • O'Grady J.
        • Praseedom R.K.
        • et al.
        Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres.
        J Hepatol. 2006; 44: 520-528
        • de Franchis R.
        • Bosch J.
        • Garcia-Tsao G.
        • Reiberger T.
        • Ripoll C.
        • Baveno V.I.I.F.
        Baveno VII - Renewing consensus in portal hypertension.
        J Hepatol. 2022; 76: 959-974
        • De Gottardi A.
        • Rautou P.E.
        • Schouten J.
        • Rubbia-Brandt L.
        • Leebeek F.
        • Trebicka J.
        • Murad S.D.
        • et al.
        Porto-sinusoidal vascular disease: proposal and description of a novel entity.
        Lancet Gastroenterol Hepatol. 2019; 4: 399-411
        • Riggio O.
        • Gioia S.
        • Pentassuglio I.
        • Nicoletti V.
        • Valente M.
        • d'Amati G.
        Idiopathic noncirrhotic portal hypertension: current perspectives.
        Hepat Med. 2016; 8: 81-88
        • Gioia S.
        • Nardelli S.
        • Pasquale C.
        • Pentassuglio I.
        • Nicoletti V.
        • Aprile F.
        • Merli M.
        • et al.
        Natural history of patients with non cirrhotic portal hypertension: comparison with patients with compensated cirrhosis.
        Dig Liver Dis. 2018; 50: 839-844
        • Schouten J.N.
        • Garcia-Pagan J.C.
        • Valla D.C.
        • Janssen H.L.
        Idiopathic noncirrhotic portal hypertension.
        Hepatology. 2011; 54: 1071-1081
        • Elkrief L.
        • Lazareth M.
        • Chevret S.
        • Paradis V.
        • Magaz M.
        • Blaise L.
        • Rubbia-Brandt L.
        • et al.
        Liver stiffness by transient elastography to detect Porto-sinusoidal vascular liver disease with portal hypertension.
        Hepatology. 2021; 74: 364-378
        • Woran K.
        • Semmler G.
        • Jachs M.
        • Simbrunner B.
        • Bauer D.J.M.
        • Binter T.
        • Pomej K.
        • et al.
        Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension.
        Clin Gastroenterol Hepatol. 2022; 20: e251-e266
        • Khanna R.
        • Sarin S.K.
        Non-cirrhotic portal hypertension - diagnosis and management.
        J Hepatol. 2014; 60: 421-441
        • Sun Y.
        • Lan X.
        • Shao C.
        • Wang T.
        • Yang Z.
        Clinical features of idiopathic portal hypertension in China: a retrospective study of 338 patients and literature review.
        J Gastroenterol Hepatol. 2019; 34: 1417-1423
        • Okuda K.
        • Kono K.
        • Ohnishi K.
        • Kimura K.
        • Omata M.
        • Koen H.
        • Nakajima Y.
        • et al.
        Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly.
        Gastroenterology. 1984; 86: 600-610
        • Goel A.
        • Madhu K.
        • Zachariah U.
        • Sajith K.G.
        • Ramachandran J.
        • Ramakrishna B.
        • Gibikote S.
        • et al.
        A study of aetiology of portal hypertension in adults (including the elderly) at a tertiary centre in southern India.
        Indian J Med Res. 2013; 137: 922-927
        • Murai Y.
        • Ohfuji S.
        • Fukushima W.
        • Tamakoshi A.
        • Yamaguchi S.
        • Hashizume M.
        • Moriyasu F.
        • et al.
        Prognostic factors in patients with idiopathic portal hypertension: two Japanese nationwide epidemiological surveys in 1999 and 2005.
        Hepatol Res. 2012; 42: 1211-1220
        • Schouten J.N.
        • Nevens F.
        • Hansen B.
        • Laleman W.
        • van den Born M.
        • Komuta M.
        • Roskams T.
        • et al.
        Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study.
        Aliment Pharmacol Ther. 2012; 35: 1424-1433
        • Buscarini E.
        • Leandro G.
        • Conte D.
        • Danesino C.
        • Daina E.
        • Manfredi G.
        • Lupinacci G.
        • et al.
        Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia.
        Dig Dis Sci. 2011; 56: 2166-2178
        • Garcia-Tsao G.
        Liver involvement in hereditary hemorrhagic telangiectasia (HHT).
        J Hepatol. 2007; 46: 499-507
        • Donaldson J.W.
        • McKeever T.M.
        • Hall I.P.
        • Hubbard R.B.
        • Fogarty A.W.
        The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study.
        Thorax. 2014; 69: 161-167
        • Grosse S.D.
        • Boulet S.L.
        • Grant A.M.
        • Hulihan M.M.
        • Faughnan M.E.
        The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia.
        Genet Med. 2014; 16: 33-39
        • Kroon S.
        • Snijder R.J.
        • Faughnan M.E.
        • Mager H.J.
        Systematic screening in hereditary hemorrhagic telangiectasia: a review.
        Curr Opin Pulm Med. 2018; 24: 260-268
        • Westermann C.J.
        • Rosina A.F.
        • De Vries V.
        • de Coteau P.A.
        The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening.
        Am J Med Genet A. 2003; 116A: 324-328
        • Buscarini E.
        • Danesino C.
        • Olivieri C.
        • Lupinacci G.
        • Zambelli A.
        Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease.
        Dig Liver Dis. 2005; 37: 635-645
        • Lesca G.
        • Olivieri C.
        • Burnichon N.
        • Pagella F.
        • Carette M.F.
        • Gilbert-Dussardier B.
        • Goizet C.
        • et al.
        Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.
        Genet Med. 2007; 9: 14-22
        • Silvain C.
        • Thevenot T.
        • Colle I.
        • Vilgrain V.
        • Dupuis-Girod S.
        • Buscarini E.
        • Valla D.
        • et al.
        Hereditary hemorrhagic telangiectasia and liver involvement: vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
        Clin Res Hepatol Gastroenterol. 2020; 44: 426-432
        • Mora-Lujan J.M.
        • Iriarte A.
        • Alba E.
        • Sanchez-Corral M.A.
        • Cerda P.
        • Cruellas F.
        • Ordi Q.
        • et al.
        Gender differences in hereditary hemorrhagic telangiectasia severity.
        Orphanet J Rare Dis. 2020; 15: 63
        • Singh S.
        • Swanson K.L.
        • Hathcock M.A.
        • Kremers W.K.
        • Pallanch J.F.
        • Krowka M.J.
        • Kamath P.S.
        Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index.
        J Hepatol. 2014; 61: 124-131
        • Iyer V.N.
        • Saberi B.
        • Heimbach J.K.
        • Larson J.J.
        • Raghavaiah S.
        • Ditah I.
        • Swanson K.
        • et al.
        Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States.
        Transplantation. 2019; 103: 1418-1424
        • Lerut J.
        • Orlando G.
        • Adam R.
        • Sabba C.
        • Pfitzmann R.
        • Klempnauer J.
        • Belghiti J.
        • et al.
        Liver transplantation for hereditary hemorrhagic telangiectasia: report of the European liver transplant registry.
        Ann Surg. 2006; 244 (discussion 862-854): 854-862
        • Thompson K.P.
        • Nelson J.
        • Kim H.
        • Pawlikowska L.
        • Marchuk D.A.
        • Lawton M.T.
        • Faughnan M.E.
        • et al.
        Predictors of mortality in patients with hereditary hemorrhagic telangiectasia.
        Orphanet J Rare Dis. 2021; 16: 12
        • Kapur N.
        • Hunt I.
        • Lunt M.
        • McBeth J.
        • Creed F.
        • Macfarlane G.
        Primary care consultation predictors in men and women: a cohort study.
        Br J Gen Pract. 2005; 55: 108-113
        • Albinana V.
        • Cuesta A.M.
        • Rojas P.I.
        • Gallardo-Vara E.
        • Recio-Poveda L.
        • Bernabeu C.
        • Botella L.M.
        Review of pharmacological strategies with repurposed drugs for hereditary hemorrhagic telangiectasia related bleeding.
        J Clin Med. 2020; 9
        • Albinana V.
        • Bernabeu-Herrero M.E.
        • Zarrabeitia R.
        • Bernabeu C.
        • Botella L.M.
        Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
        Thromb Haemost. 2010; 103: 525-534
        • Eivazi B.
        • Werner J.A.
        • Roessler M.
        • Negm H.
        • Teymoortash A.
        Lack of significant estrogen and progesterone receptor expression in nasal telangiectasias in hereditary hemorrhagic telangiectasia: an immunohistochemical analysis.
        Acta Otolaryngol. 2012; 132: 86-89
        • Pau H.
        • Carney A.S.
        • Walker R.
        • Murty G.E.
        Is oestrogen therapy justified in the treatment of hereditary haemorrhagic telangiectasia: a biochemical evaluation.
        Clin Otolaryngol Allied Sci. 2000; 25: 570-576
        • Minami K.
        • Haji T.
        Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia.
        Acta Otolaryngol. 2016; 136: 528-531
        • Yaniv E.
        • Preis M.
        • Hadar T.
        • Shvero J.
        • Haddad M.
        Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
        Laryngoscope. 2009; 119: 284-288
        • Ruiz S.
        • Zhao H.
        • Chandakkar P.
        • Papoin J.
        • Choi H.
        • Nomura-Kitabayashi A.
        • Patel R.
        • et al.
        Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
        J Clin Invest. 2020; 130: 942-957
        • Sandhu B.S.
        • Sanyal A.J.
        Pregnancy and liver disease.
        Gastroenterol Clin North Am. 2003; 32 (407-436, ix)
        • Aggarwal N.
        • Sawhney H.
        • Vasishta K.
        • Dhiman R.K.
        • Chawla Y.
        Non-cirrhotic portal hypertension in pregnancy.
        Int J Gynaecol Obstet. 2001; 72: 1-7
        • Andrade F.
        • Shukla A.
        • Bureau C.
        • Senzolo M.
        • D'Alteroche L.
        • Heurgue A.
        • Garcia-Pagan J.C.
        • et al.
        Pregnancy in idiopathic non-cirrhotic portal hypertension: a multicentric study on maternal and fetal management and outcome.
        J Hepatol. 2018; 69: 1242-1249
        • Mustafa R.
        • Ahmed S.
        • Gupta A.
        • Venuto R.C.
        A comprehensive review of hypertension in pregnancy.
        J Pregnancy. 2012; 2012105918
        • Lopez-Mendez E.
        • Avila-Escobedo L.
        Pregnancy and portal hypertension a pathology view of physiologic changes.
        Ann Hepatol. 2006; 5: 219-223
        • Aggarwal N.
        • Chopra S.
        • Raveendran A.
        • Suri V.
        • Dhiman R.K.
        • Chawla Y.K.
        Extra hepatic portal vein obstruction and pregnancy outcome: largest reported experience.
        J Obstet Gynaecol Res. 2011; 37: 575-580
        • Kochhar R.
        • Kumar S.
        • Goel R.C.
        • Sriram P.V.
        • Goenka M.K.
        • Singh K.
        Pregnancy and its outcome in patients with noncirrhotic portal hypertension.
        Dig Dis Sci. 1999; 44: 1356-1361
        • Pajor A.
        • Lehoczky D.
        Pregnancy and extrahepatic portal hypertension. Review and report on the management.
        Gynecol Obstet Invest. 1990; 30: 193-197
        • Douketis J.D.
        • Spyropoulos A.C.
        • Spencer F.A.
        • Mayr M.
        • Jaffer A.K.
        • Eckman M.H.
        • Dunn A.S.
        • et al.
        Perioperative management of antithrombotic therapy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines.
        Chest. 2012; 141: e326S-e350S
        • Hoekstra J.
        • Seijo S.
        • Rautou P.E.
        • Ducarme G.
        • Boudaoud L.
        • Luton D.
        • Alijotas-Reig J.
        • et al.
        Pregnancy in women with portal vein thrombosis: results of a multicentric European study on maternal and fetal management and outcome.
        J Hepatol. 2012; 57: 1214-1219
        • Rautou P.E.
        • Angermayr B.
        • Garcia-Pagan J.C.
        • Moucari R.
        • Peck-Radosavljevic M.
        • Raffa S.
        • Bernuau J.
        • et al.
        Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes.
        J Hepatol. 2009; 51: 47-54
        • Linkins L.A.
        • Dans A.L.
        • Moores L.K.
        • Bona R.
        • Davidson B.L.
        • Schulman S.
        • Crowther M.
        Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: american College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
        Chest. 2012; 141: e495S-e530S
        • Bates S.M.
        • Greer I.A.
        • Middeldorp S.
        • Veenstra D.L.
        • Prabulos A.M.
        • Vandvik P.O
        VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: american College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
        Chest. 2012; 141: e691S-e736S
        • Greer I.A.
        • Nelson-Piercy C.
        Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.
        Blood. 2005; 106: 401-407
        • Beyer-Westendorf J.
        • Marten S
        Reproductive issues in women on direct oral anticoagulants.
        Res Pract Thromb Haemost. 2021; 5: e12512
        • Beyer-Westendorf J.
        • Tittl L.
        • Bistervels I.
        • Middeldorp S.
        • Schaefer C.
        • Paulus W.
        • Thomas W.
        • et al.
        Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study.
        Lancet Haematol. 2020; 7: e884-e891
        • Wiegers H.
        • Hamulyak E.N.
        • Damhuis S.E.
        • van Duuren J.R.
        • Darwish Murad S.
        • Scheres L.
        • Gordijn S.J.
        • et al.
        Pregnancy outcomes in women with Budd-Chiari syndrome or portal vein thrombosis - a multicentre retrospective cohort study.
        BJOG. 2022; 129: 608-617
        • Payance A.
        • Ceccaldi P.F.
        • De Raucourt E.
        • Valla D.
        • Hillaire S.
        • Dutheil D.
        • Hernandez-Gea V.
        • et al.
        Pregnancy and vascular liver diseases: vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
        Clin Res Hepatol Gastroenterol. 2020; 44: 433-437
        • Ren W.
        • Li X.
        • Jia J.
        • Xia Y.
        • Hu F.
        • Xu Z.
        Prevalence of Budd-Chiari Syndrome during Pregnancy or Puerperium: a Systematic Review and Meta-Analysis.
        Gastroenterol Res Pract. 2015; 2015839875
        • Darwish Murad S.
        • Plessier A.
        • Hernandez-Guerra M.
        • Fabris F.
        • Eapen C.E.
        • Bahr M.J.
        • Trebicka J.
        • et al.
        Etiology, management, and outcome of the Budd-Chiari syndrome.
        Ann Intern Med. 2009; 151: 167-175
        • Mohanty D.
        • Shetty S.
        • Ghosh K.
        • Pawar A.
        • Abraham P.
        Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India.
        Hepatology. 2001; 34: 666-670
        • Almousa S.
        • Lamprianidou E.
        • Kitsoulis G.
        The effectiveness of stabilising exercises in pelvic girdle pain during pregnancy and after delivery: a systematic review.
        Physiother Res Int. 2018; 23
        • Bissonnette J.
        • Durand F.
        • de Raucourt E.
        • Ceccaldi P.F.
        • Plessier A.
        • Valla D.
        • Rautou P.E.
        Pregnancy and vascular liver disease.
        J Clin Exp Hepatol. 2015; 5: 41-50
        • Casini A.
        • Fontana P.
        • Lecompte T.P.
        Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management.
        J Thromb Haemost. 2013; 11: 1215-1227
        • Randi M.L.
        • Bertozzi I.
        • Rumi E.
        • Elena C.
        • Finazzi G.
        • Vianelli N.
        • Polverelli N.
        • et al.
        Pregnancy complications predict thrombotic events in young women with essential thrombocythemia.
        Am J Hematol. 2014; 89: 306-309
        • Shukla A.
        • Sadalage A.
        • Gupta D.
        • Gupte A.
        • Mahapatra A.
        • Mazumder D.
        • Shah C.
        • et al.
        Pregnancy outcomes in women with Budd Chiari Syndrome before onset of symptoms and after treatment.
        Liver Int. 2018; 38: 754-759
        • Denninger M.H.
        • Chait Y.
        • Casadevall N.
        • Hillaire S.
        • Guillin M.C.
        • Bezeaud A.
        • Erlinger S.
        • et al.
        Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.
        Hepatology. 2000; 31: 587-591
        • Dilawari J.B.
        • Bambery P.
        • Chawla Y.
        • Kaur U.
        • Bhusnurmath S.R.
        • Malhotra H.S.
        • Sood G.K.
        • et al.
        Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature.
        Medicine (Baltimore). 1994; 73: 21-36
        • Huguet C.
        • Deliere T.
        • Ollvier J.M.
        • Levy V.G.
        Budd-Chiari syndrome with thrombosis of the inferior vena cava: long-term patency of meso-caval and cavoatrial prosthetic bypass.
        Surgery. 1984; 95: 108-111
        • Khuroo M.S.
        • Datta D.V.
        Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract.
        Am J Med. 1980; 68: 113-121
        • Martinelli P.
        • Maruotti G.M.
        • Coppola A.
        • Agangi A.
        • Paladini D.
        • Grandone E.
        • Di Minno G.
        Pregnancy in a woman with a history of Budd-Chiari syndrome treated by porto-systemic shunt, protein C deficiency and bicornuate uterus.
        Thromb Haemost. 2006; 95: 1033-1034
        • Powell-Jackson P.R.
        • Melia W.
        • Canalese J.
        • Pickford R.B.
        • Portmann B.
        • Williams R
        Budd-Chiari Syndrome: clinical patterns and therapy.
        Q J Med. 1982; 51: 79-88
        • Aggarwal N.
        • Suri V.
        • Chopra S.
        • Sikka P.
        • Dhiman R.K.
        • Chawla Y.K.
        Pregnancy outcome in Budd Chiari Syndrome–a tertiary care centre experience.
        Arch Gynecol Obstet. 2013; 288: 949-952
        • Khan F.
        • Rowe I.
        • Martin B.
        • Knox E.
        • Johnston T.
        • Elliot C.
        • Lester W.
        • et al.
        Outcomes of pregnancy in patients with known Budd-Chiari syndrome.
        World J Hepatol. 2017; 9: 945-952
        • Rautou P.E.
        • Plessier A.
        • Bernuau J.
        • Denninger M.H.
        • Moucari R.
        • Valla D.
        Pregnancy: a risk factor for Budd-Chiari syndrome?.
        Gut. 2009; 58: 606-608
        • Ammon Avalos L.
        • Galindo C.
        • Li D.K
        A systematic review to calculate background miscarriage rates using life table analysis.
        Birth Defects Res A Clin Mol Teratol. 2012; 94: 417-423
        • Bruckner T.A.
        • Mortensen L.H.
        • Catalano R.A.
        Spontaneous Pregnancy Loss in Denmark Following Economic Downturns.
        Am J Epidemiol. 2016; 183: 701-708
        • Kampman M.A.
        • Bilardo C.M.
        • Mulder B.J.
        • Aarnoudse J.G.
        • Ris-Stalpers C.
        • van Veldhuisen D.J.
        • Pieper P.G.
        Maternal cardiac function, uteroplacental Doppler flow parameters and pregnancy outcome: a systematic review.
        Ultrasound Obstet Gynecol. 2015; 46: 21-28
        • Cazals-Hatem D.
        • Hillaire S.
        • Rudler M.
        • Plessier A.
        • Paradis V.
        • Condat B.
        • Francoz C.
        • et al.
        Obliterative portal venopathy: portal hypertension is not always present at diagnosis.
        J Hepatol. 2011; 54: 455-461
        • Siramolpiwat S.
        • Seijo S.
        • Miquel R.
        • Berzigotti A.
        • Garcia-Criado A.
        • Darnell A.
        • Turon F.
        • et al.
        Idiopathic portal hypertension: natural history and long-term outcome.
        Hepatology. 2014; 59: 2276-2285
        • Goldenberg R.L.
        • Culhane J.F.
        • Iams J.D.
        • Romero R.
        Epidemiology and causes of preterm birth.
        Lancet. 2008; 371: 75-84
        • Muglia L.J.
        • Katz M.
        The enigma of spontaneous preterm birth.
        N Engl J Med. 2010; 362: 529-535
        • James A.H.
        • Jamison M.G.
        • Brancazio L.R.
        • Myers E.R.
        Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.
        Am J Obstet Gynecol. 2006; 194: 1311-1315
        • Sumana G.
        • Dadhwal V.
        • Deka D.
        • Mittal S.
        Non-cirrhotic portal hypertension and pregnancy outcome.
        J Obstet Gynaecol Res. 2008; 34: 801-804